Induction of CD11a/leukocyte function antigen-1 and CD54/intercellular adhesion molecule-1 on hairy cell leukemia cells is accompanied by enhanced susceptibility to T-cell but not lymphokine-activated killer- cell cytotoxicity [see comments]

Autor: JH Jansen, D van der Harst, GJ Wientjens, YM Kooy-Winkelaar, A Brand, R Willemze, HC Kluin-Nelemans

Publikováno v: Blood. 80:478-483

Some B-cell neoplasms, including hairy cell leukemia (HCL), lack expression of the adhesion molecule leukocyte function antigen-1 (LFA- 1/CD11a). Additionally, HCL cells express relatively low amounts of intercellular adhesion molecule-1 (ICAM-1/CD54

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::1c6b5711fba53ed37d818718bcca2d1a
https://doi.org/10.1182/blood.v80.2.478.bloodjournal802478

Porcine membranoproliferative glomerulonephritis type II: an autosomal recessive deficiency of factor H

Autor: AM Grondahl, JH Jansen, K Hogasen

Publikováno v: The Veterinary record. 137(10)

Hypocomplementaemic hereditary membranoproliferative glomerulonephritis (MPGN) type II is a common cause of the early loss of piglets in the Norwegian Yorkshire breed. The disease is associated with extensive complement activation due to a deficiency

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d0c9c94bf6e7e624bced7284a14ed5eb
https://pubmed.ncbi.nlm.nih.gov/8533215

A new non-Hodgkin's B-cell line (DoHH2) with a chromosomal translocation t(14;18)(q32;q21)

Autor: Johanna Cornelia Kluin-Nelemans, Limpens J, Meerabux J, Gc, Beverstock, Jh, Jansen, de Jong D, Pm, Kluin

Publikováno v: Europe PubMed Central

A spontaneously growing EBV-negative B-cell line (DoHH2) was established from the pleural fluid cells of a 60-year-old man with centroblastic/centrocytic non-Hodgkin's lymphoma, that had transformed into an immunoblastic lymphoma. The pleural fluid c

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::02185c259235992cb9484233fc777255
https://pubmed.ncbi.nlm.nih.gov/1849602

Inhibitory effect of interleukin-4 on the proliferation of acute myeloid leukemia cells with myelo-monocytic differentiation (AML-M4/M5); the role of interleukin-6

Autor: Jh, Jansen, We, Fibbe, Gj, Wientjens, Willemze R, Johanna Cornelia Kluin-Nelemans

Publikováno v: Europe PubMed Central

Since interleukin-4 (IL-4) specifically inhibits monocytic colony formation in human bone marrow cultures, we investigated whether a similar inhibition could be observed in cultures of optimally stimulated acute myeloid leukemia cells with myelomonoc

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::db1e09996346d5e5e671e67f2a6bd5ee
http://europepmc.org/abstract/med/8464242

HMX3 is a critical vulnerability in MECOM-negative KMT2A::MLLT3 acute myelomonocytic leukemia.

Autor: Arza-Apalategi S; Department of Laboratory Medicine, Laboratory of Hematology, Radboud University Medical Center, Nijmegen, The Netherlands., Heuts BMH; Department of Molecular Biology, Faculty of Science, Radboud Institute for Molecular Life Sciences, Oncode Institute, Radboud University, Nijmegen, The Netherlands., Bergevoet SM; Department of Laboratory Medicine, Laboratory of Hematology, Radboud University Medical Center, Nijmegen, The Netherlands., Meering R; Department of Laboratory Medicine, Laboratory of Hematology, Radboud University Medical Center, Nijmegen, The Netherlands., Gilissen D; Department of Laboratory Medicine, Laboratory of Hematology, Radboud University Medical Center, Nijmegen, The Netherlands., Jansen PWTC; Department of Molecular Biology, Faculty of Science, Radboud Institute for Molecular Life Sciences, Oncode Institute, Radboud University, Nijmegen, The Netherlands., Krippner-Heidenreich A; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Valk PJM; Department Hematology, Erasmus MC, Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands., Vermeulen M; Department of Molecular Biology, Faculty of Science, Radboud Institute for Molecular Life Sciences, Oncode Institute, Radboud University, Nijmegen, The Netherlands., Heidenreich O; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Haferlach T; MLL Munich Leukemia Laboratory, Munich, Germany., Jansen JH; Department of Laboratory Medicine, Laboratory of Hematology, Radboud University Medical Center, Nijmegen, The Netherlands., Martens JHA; Department of Molecular Biology, Faculty of Science, Radboud Institute for Molecular Life Sciences, Oncode Institute, Radboud University, Nijmegen, The Netherlands., van der Reijden BA; Department of Laboratory Medicine, Laboratory of Hematology, Radboud University Medical Center, Nijmegen, The Netherlands. Bert.vanderReijden@radboudumc.nl.

Publikováno v: Leukemia [Leukemia] 2024 Dec 04. Date of Electronic Publication: 2024 Dec 04.